High blood pressure is a major health threat, but getting it under control often requires more than just a doctor's visit. A new study is trying to find out if a coordinated, team-based approach can make a real difference for patients in everyday clinics. The trial involves over 1,700 people across 40 primary care clinics in Colombia and Jamaica. One group of clinics is using a comprehensive strategy that includes team training, care coordination, home blood pressure monitoring, and easier access to medication. The other group is focusing on training providers in current guidelines. The goal is to see which approach leads to better blood pressure control after 18 months. It's important to know that this article only describes the study's design and plan. The trial is still in progress, so there are no results yet on whether the team-based strategy actually works better or is safe. We don't know if patients' blood pressure improved or if there were any problems. The findings, when they come, could help shape how high blood pressure is managed in similar settings around the world.
Team-based hypertension strategy versus provider training tested in Colombian and Jamaican primary care clinicsCan a team-based approach help more people control their blood pressure?
AI-generated summary of the cited source, checked by automated accuracy review. How we work
This study design and rationale article outlines a cluster randomized trial (effectiveness-implementation hybrid type-2 design) conducted in 40 primary care clinics in Colombia and Jamaica. The planned enrollment was 1,680 participants, with 1,707 ultimately recruited. The trial compares a comprehensive team-based strategy—including healthcare team training, care coordination, task sharing, blood pressure audit and feedback, home BP monitoring, health coaching, single-pill combination therapy, and increased medication access—against a provider-training strategy focused on implementing current hypertension guidelines.
The primary outcomes are clinical effectiveness, measured as the difference in mean change of systolic BP from baseline to 18 months between groups, and implementation, assessed via a composite fidelity score to key strategy components. Secondary outcomes are not specified. The follow-up period is 18 months. No results for any outcomes, including blood pressure changes or fidelity scores, are reported in this protocol paper, as the study is described as being in follow-up.
Safety and tolerability data, including adverse events, serious adverse events, and discontinuations, are not reported. The article does not list specific study limitations. The authors note that if proven effective, this team-based approach could be scaled up in primary care throughout low- and middle-income countries (LMICs). Funding sources and conflicts of interest are not reported.
This is solely a trial protocol; no efficacy, safety, or implementation results are available. The restrained practice relevance is that the described strategy represents a potential model for hypertension management in LMIC primary care settings, but its value cannot be assessed until the trial is completed and results are published.